08/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

08/2023

Aug 28, 2023, 18:21 | Opinion
Sarah Sammons: Don’t assume all stage IV cancer patients have “poor prognosis” if it impacts your decisions.
Quoting Sarah Sammons, the Associate Director of EMBRACE Metastatic Breast Cancer Program at Dana-Farber Breast…
Aug 28, 2023, 18:14 | Positive
Ghida Talal: Nothing compares to the beautiful smiles of our children as they play happily while taking a break from their treatment.
Quoting Ghida Talal, the Chairperson of the Board of Trustees of the King Hussein Cancer…
Aug 28, 2023, 18:03 | Blog
Naveen Pemmaraju: Make sure to follow on medtwitter our superstar brilliant hematology/oncology fellow MD Dr Hima Atluri.
Quoting Naveen Pemmaraju, the Executive Director of Cancer Medicine at MD Anderson Cancer Center, Texas,…
Aug 28, 2023, 17:53 | Opinion
Panagis Galiatsatos: Clearly we need better handling of physician burnout or maybe we just send all doctors to Greece for some time.
Quoting Panagis Galiatsatos, Pulmonary/CCM Associate Professor on Twitter: "Seeing patients all morning and each one:…
Aug 28, 2023, 17:40 | Insight
Vivek Subbiah: Lurbinectedin was approved for Small cell Lung in USA and now is also approved in Canada, Australia, Singapore, the United Arab Emirates, Qatar, South Korea, Ecuador, Mexico, Israel and Switzerland.
Aug 27, 2023, 19:01 | Insight
Naveen Pemmaraju: New paper alert from our group led by our doctor Montalban Bravo and professor Garcia Manero.
Quoting Naveen Pemmaraju, the Executive Director of Cancer Medicine at the MD Anderson Cancer Center,…
Aug 27, 2023, 19:00 | Stories
Four-year-old Hunter is a very happy boy, who loves making people laugh, being silly, cars, and riding his balance bike. - St. Baldrick's Foundation
St. Baldrick's Foundation shared the following story on LinkedIn: "Four-year-old Hunter is a very happy…
Aug 27, 2023, 18:59 | Insight
Antonio Marra: In an analysis of more than 28k pts, pancreatic acinar cell carcinoma was the cancer type with the highest prevalence of gBRCA2 and HRD features.
Quoting Antonio Marra, medical oncologist at the European Institute of Oncology, on Twitter: "Our latest…
Aug 27, 2023, 18:58 | Insight
Vivek Subbiah: The 3rd KRAS G12C kid on the block.
According to Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute:…
Aug 27, 2023, 18:52 | Stories
Kristiyana Kaneva: Take time to look back, no less frequently than once in a decade.
Quoting Kristiyana Kaneva, Senior Medical Director of Clinical Development and Pediatric Oncology at Tempus Labs,…
All: 539 Posts: 61 - 70